Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Rigel Pharmaceuticals Inc Share Price

RIGL

NSQ

$35.72

+$0.17

(0.48%)

Industry: Biotechnology Sector: Health Care

Rigel Pharmaceuticals Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

Rigel Pharmaceuticals Inc Share Price Chart

Rigel Pharmaceuticals Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$645.28M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

5.5444

Volume

This is the total number of shares traded during the most recent trading day.

370.75K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

1.09

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$15.5 L

$52.24 H

$35.72

About Rigel Pharmaceuticals Inc, Common Stock

Rigel Pharmaceuticals, Inc., a biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer. The company's commercialized products include Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia; Rezlidhia, a non-intensive monotherapy to treat adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test; and GAVRETO, a once daily, small molecule, oral, kinase inhibitor for the treatment of adult patients with metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC), as well as to treat adult and pediatric patients twelve years of age and older with advanced or metastatic RET fusion-positive thyroid cancer. It also develops R289, an oral interleukin receptor-associated kinases 1 and 4 (IRAK1/4) inhibitor for the treatment of hematology-oncology, autoimmune, and inflammatory diseases, as well as to treat lower-risk myelodysplastic syndrome. In addition, the company has product candidates in clinical development with partners BerGenBio ASA, Eli Lilly and Company, and Daiichi Sankyo. It has strategic development collaboration with The University of Texas MD Anderson Cancer Center for the development of Olutasidenib in AML and other hematologic cancers with IDH1mutations, as well as with collaborative network for neuro-oncology clinical trials to evaluate Olutasidenib in combination with temozolomide in patients with high-grade glioma harboring an IDH1 mutation. Rigel Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in South San Francisco, California. more

Industry: BiotechnologySector: Health Care

Rigel Pharmaceuticals Inc Stock Returns

Time Frame	RIGL	Sector	S&P500
1-Week Return	2.23%	0.72%	-1.31%
1-Month Return	-1.71%	1.27%	0.78%
3-Month Return	-22.72%	3.13%	3.46%
6-Month Return	-10.86%	15.81%	6.19%
1-Year Return	72.23%	8.89%	11.68%
3-Year Return	124.65%	20.79%	71.21%
5-Year Return	-24.96%	35.89%	74.81%
10-Year Return	49.46%	138.44%	256.59%

Time Frame	RIGL	Sector	S&P500
1-Week Return	215.82%	45.37%	-49.72%
1-Month Return	-18.93%	16.60%	9.91%
3-Month Return	-64.84%	13.31%	14.79%
6-Month Return	-20.79%	34.67%	12.95%
1-Year Return	72.23%	8.89%	11.68%
3-Year Return	30.97%	6.50%	19.63%
5-Year Return	-5.58%	6.33%	11.82%
10-Year Return	4.10%	9.08%	13.56%

Rigel Pharmaceuticals Inc Financials

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	108.62M	149.24M	120.24M	116.88M	179.28M	[{"date":"2020-12-31","value":60.59,"profit":true},{"date":"2021-12-31","value":83.24,"profit":true},{"date":"2022-12-31","value":67.07,"profit":true},{"date":"2023-12-31","value":65.2,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue	895.00K	1.08M	1.75M	7.11M	18.65M	[{"date":"2020-12-31","value":4.8,"profit":true},{"date":"2021-12-31","value":5.81,"profit":true},{"date":"2022-12-31","value":9.38,"profit":true},{"date":"2023-12-31","value":38.13,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit	107.73M	148.15M	118.49M	109.77M	160.63M	[{"date":"2020-12-31","value":67.06,"profit":true},{"date":"2021-12-31","value":92.23,"profit":true},{"date":"2022-12-31","value":73.77,"profit":true},{"date":"2023-12-31","value":68.34,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin	99.18%	99.27%	98.55%	93.92%	89.60%	[{"date":"2020-12-31","value":99.9,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.27,"profit":true},{"date":"2023-12-31","value":94.6,"profit":true},{"date":"2024-12-31","value":90.25,"profit":true}]

Operating Expenses	136.70M	160.65M	174.04M	130.26M	136.44M	[{"date":"2020-12-31","value":78.54,"profit":true},{"date":"2021-12-31","value":92.3,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":74.85,"profit":true},{"date":"2024-12-31","value":78.39,"profit":true}]
Operating Income	(28.97M)	(12.50M)	(55.55M)	(20.49M)	24.19M	[{"date":"2020-12-31","value":-119.76,"profit":false},{"date":"2021-12-31","value":-51.65,"profit":false},{"date":"2022-12-31","value":-229.62,"profit":false},{"date":"2023-12-31","value":-84.7,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	(1.54M)	(9.63M)	(6.05M)	(8.65M)	(11.65M)	[{"date":"2020-12-31","value":-154200000,"profit":false},{"date":"2021-12-31","value":-962600000,"profit":false},{"date":"2022-12-31","value":-604600000,"profit":false},{"date":"2023-12-31","value":-864900000,"profit":false},{"date":"2024-12-31","value":-1165200000,"profit":false}]
Pre-Tax Income	(29.74M)	(17.31M)	(58.57M)	(25.09M)	18.37M	[{"date":"2020-12-31","value":-161.95,"profit":false},{"date":"2021-12-31","value":-94.24,"profit":false},{"date":"2022-12-31","value":-318.92,"profit":false},{"date":"2023-12-31","value":-136.62,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes	647.00K	605.00K	3.02M	2.27M	881.00K	[{"date":"2020-12-31","value":21.4,"profit":true},{"date":"2021-12-31","value":20.01,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":75.16,"profit":true},{"date":"2024-12-31","value":29.14,"profit":true}]
Income After Taxes	(30.39M)	(17.91M)	(61.60M)	(27.36M)	17.48M	[{"date":"2020-12-31","value":-173.81,"profit":false},{"date":"2021-12-31","value":-102.45,"profit":false},{"date":"2022-12-31","value":-352.28,"profit":false},{"date":"2023-12-31","value":-156.49,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Income From Continuous Operations	(29.74M)	(17.91M)	(58.57M)	(24.43M)	17.48M	[{"date":"2020-12-31","value":-170.11,"profit":false},{"date":"2021-12-31","value":-102.45,"profit":false},{"date":"2022-12-31","value":-334.99,"profit":false},{"date":"2023-12-31","value":-139.7,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(29.74M)	(17.91M)	(58.57M)	(25.09M)	17.48M	[{"date":"2020-12-31","value":-170.11,"profit":false},{"date":"2021-12-31","value":-102.45,"profit":false},{"date":"2022-12-31","value":-334.99,"profit":false},{"date":"2023-12-31","value":-143.5,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

EPS (Diluted)	(0.16)	(0.11)	(0.34)	(0.15)	1.39	[{"date":"2020-12-31","value":-11.51,"profit":false},{"date":"2021-12-31","value":-7.91,"profit":false},{"date":"2022-12-31","value":-24.46,"profit":false},{"date":"2023-12-31","value":-10.49,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	37.39%	(19.43%)	(2.79%)	53.38%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":70.04,"profit":true},{"date":"2022-12-31","value":-36.39,"profit":false},{"date":"2023-12-31","value":-5.23,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue	-	21.01%	61.50%	306.52%	162.26%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":6.85,"profit":true},{"date":"2022-12-31","value":20.06,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":52.94,"profit":true}]
Gross Profit	-	37.53%	(20.02%)	(7.36%)	46.33%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":81,"profit":true},{"date":"2022-12-31","value":-43.21,"profit":false},{"date":"2023-12-31","value":-15.89,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin	-	0.10%	(0.73%)	(4.70%)	(4.60%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-740.97,"profit":false},{"date":"2023-12-31","value":-4740.13,"profit":false},{"date":"2024-12-31","value":-4640.2,"profit":false}]

Operating Expenses	-	17.52%	8.34%	(25.15%)	4.74%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":47.59,"profit":true},{"date":"2023-12-31","value":-143.58,"profit":false},{"date":"2024-12-31","value":27.06,"profit":true}]
Operating Income	-	(56.87%)	344.54%	(63.11%)	(218.06%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-16.51,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-18.32,"profit":false},{"date":"2024-12-31","value":-63.29,"profit":false}]
Total Non-Operating Income/Expense	-	524.25%	(37.19%)	43.05%	34.72%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-7.09,"profit":false},{"date":"2023-12-31","value":8.21,"profit":true},{"date":"2024-12-31","value":6.62,"profit":true}]
Pre-Tax Income	-	(41.81%)	238.40%	(57.16%)	(173.20%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-17.54,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-23.98,"profit":false},{"date":"2024-12-31","value":-72.65,"profit":false}]
Income Taxes	-	(6.49%)	399.67%	(24.84%)	(61.22%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1.62,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-6.22,"profit":false},{"date":"2024-12-31","value":-15.32,"profit":false}]
Income After Taxes	-	(41.05%)	243.84%	(55.58%)	(163.90%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-16.84,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-22.79,"profit":false},{"date":"2024-12-31","value":-67.22,"profit":false}]

Income From Continuous Operations	-	(39.77%)	226.97%	(58.30%)	(171.58%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-17.52,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-25.68,"profit":false},{"date":"2024-12-31","value":-75.6,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	(39.77%)	226.97%	(57.16%)	(169.69%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-17.52,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-25.19,"profit":false},{"date":"2024-12-31","value":-74.76,"profit":false}]

EPS (Diluted)	-	(31.25%)	209.09%	(57.12%)	(1053.36%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-14.95,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-27.32,"profit":false},{"date":"2024-12-31","value":-503.78,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	55.31M	57.60M	53.33M	101.69M	69.46M	[{"date":"2024-09-30","value":54.39,"profit":true},{"date":"2024-12-31","value":56.64,"profit":true},{"date":"2025-03-31","value":52.45,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":68.31,"profit":true}]
Cost of Revenue	8.03M	5.79M	4.41M	4.50M	4.75M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":72.13,"profit":true},{"date":"2025-03-31","value":54.93,"profit":true},{"date":"2025-06-30","value":56.12,"profit":true},{"date":"2025-09-30","value":59.22,"profit":true}]
Gross Profit	47.28M	51.81M	48.92M	97.18M	64.71M	[{"date":"2024-09-30","value":48.65,"profit":true},{"date":"2024-12-31","value":53.31,"profit":true},{"date":"2025-03-31","value":50.34,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":66.59,"profit":true}]
Gross Margin	85.49%	89.95%	91.73%	95.57%	93.16%	[{"date":"2024-09-30","value":89.45,"profit":true},{"date":"2024-12-31","value":94.12,"profit":true},{"date":"2025-03-31","value":95.98,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":97.47,"profit":true}]

Operating Expenses	33.23M	35.15M	36.15M	36.08M	36.29M	[{"date":"2024-09-30","value":91.56,"profit":true},{"date":"2024-12-31","value":96.87,"profit":true},{"date":"2025-03-31","value":99.62,"profit":true},{"date":"2025-06-30","value":99.42,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Operating Income	14.06M	16.66M	12.77M	61.10M	28.42M	[{"date":"2024-09-30","value":23,"profit":true},{"date":"2024-12-31","value":27.26,"profit":true},{"date":"2025-03-31","value":20.9,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":46.51,"profit":true}]
Total Non-Operating Income/Expense	(3.27M)	(2.87M)	(2.52M)	(2.24M)	(1.60M)	[{"date":"2024-09-30","value":-327000000,"profit":false},{"date":"2024-12-31","value":-286600000,"profit":false},{"date":"2025-03-31","value":-252400000,"profit":false},{"date":"2025-06-30","value":-224200000,"profit":false},{"date":"2025-09-30","value":-160000000,"profit":false}]
Pre-Tax Income	12.42M	15.22M	11.51M	59.98M	27.62M	[{"date":"2024-09-30","value":20.71,"profit":true},{"date":"2024-12-31","value":25.38,"profit":true},{"date":"2025-03-31","value":19.19,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":46.05,"profit":true}]
Income Taxes	-	881.00K	65.00K	369.00K	(280.00K)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":7.38,"profit":true},{"date":"2025-06-30","value":41.88,"profit":true},{"date":"2025-09-30","value":-31.78,"profit":false}]
Income After Taxes	-	14.34M	11.45M	59.61M	27.90M	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":24.06,"profit":true},{"date":"2025-03-31","value":19.2,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":46.8,"profit":true}]

Income From Continuous Operations	12.42M	14.34M	11.45M	59.61M	27.90M	[{"date":"2024-09-30","value":20.84,"profit":true},{"date":"2024-12-31","value":24.06,"profit":true},{"date":"2025-03-31","value":19.2,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":46.8,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	12.42M	14.34M	11.45M	59.61M	27.90M	[{"date":"2024-09-30","value":20.84,"profit":true},{"date":"2024-12-31","value":24.06,"profit":true},{"date":"2025-03-31","value":19.2,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":46.8,"profit":true}]

EPS (Diluted)	0.70	0.80	0.63	3.28	1.46	[{"date":"2024-09-30","value":21.34,"profit":true},{"date":"2024-12-31","value":24.39,"profit":true},{"date":"2025-03-31","value":19.21,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":44.51,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	4.14%	(7.40%)	90.66%	(31.69%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":4.57,"profit":true},{"date":"2025-03-31","value":-8.16,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-34.95,"profit":false}]
Cost of Revenue	-	(27.87%)	(23.84%)	2.15%	5.53%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-504.16,"profit":false},{"date":"2025-03-31","value":-431.2,"profit":false},{"date":"2025-06-30","value":38.97,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Profit	-	9.57%	(5.56%)	98.64%	(33.41%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":9.7,"profit":true},{"date":"2025-03-31","value":-5.64,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-33.88,"profit":false}]
Gross Margin	-	5.22%	1.98%	4.18%	(2.53%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":38.01,"profit":true},{"date":"2025-06-30","value":80.17,"profit":true},{"date":"2025-09-30","value":-48.39,"profit":false}]

Operating Expenses	-	5.80%	2.84%	(0.20%)	0.58%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":49,"profit":true},{"date":"2025-06-30","value":-3.48,"profit":false},{"date":"2025-09-30","value":10.08,"profit":true}]
Operating Income	-	18.49%	(23.31%)	378.38%	(53.49%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":4.89,"profit":true},{"date":"2025-03-31","value":-6.16,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-14.14,"profit":false}]
Total Non-Operating Income/Expense	-	(12.35%)	(11.93%)	(11.17%)	(28.64%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Pre-Tax Income	-	22.55%	(24.38%)	421.08%	(53.95%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":5.36,"profit":true},{"date":"2025-03-31","value":-5.79,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-12.81,"profit":false}]
Income Taxes	-	-	(92.62%)	467.69%	(175.88%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-19.8,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-37.61,"profit":false}]
Income After Taxes	-	-	(20.19%)	420.82%	(53.20%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-4.8,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-12.64,"profit":false}]

Income From Continuous Operations	-	15.46%	(20.19%)	420.82%	(53.20%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":3.67,"profit":true},{"date":"2025-03-31","value":-4.8,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-12.64,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	15.46%	(20.19%)	420.82%	(53.20%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":3.67,"profit":true},{"date":"2025-03-31","value":-4.8,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-12.64,"profit":false}]

EPS (Diluted)	-	14.29%	(21.25%)	420.63%	(55.49%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":3.4,"profit":true},{"date":"2025-03-31","value":-5.05,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-13.19,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	88.98M	154.47M	115.90M	99.27M	135.10M	[{"date":"2020-12-31","value":57.61,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":75.03,"profit":true},{"date":"2023-12-31","value":64.26,"profit":true},{"date":"2024-12-31","value":87.46,"profit":true}]
Non-current Assets	21.39M	12.86M	18.38M	17.96M	28.87M	[{"date":"2020-12-31","value":74.1,"profit":true},{"date":"2021-12-31","value":44.54,"profit":true},{"date":"2022-12-31","value":63.64,"profit":true},{"date":"2023-12-31","value":62.2,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	110.38M	167.33M	134.28M	117.22M	163.98M	[{"date":"2020-12-31","value":65.97,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":80.25,"profit":true},{"date":"2023-12-31","value":70.06,"profit":true},{"date":"2024-12-31","value":98,"profit":true}]

Total Liabilities
Current Liabilities	40.84M	63.55M	65.21M	53.27M	63.30M	[{"date":"2020-12-31","value":62.63,"profit":true},{"date":"2021-12-31","value":97.46,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":81.68,"profit":true},{"date":"2024-12-31","value":97.07,"profit":true}]
Non-current Liabilities	35.51M	73.40M	82.68M	92.60M	97.39M	[{"date":"2020-12-31","value":36.46,"profit":true},{"date":"2021-12-31","value":75.37,"profit":true},{"date":"2022-12-31","value":84.9,"profit":true},{"date":"2023-12-31","value":95.08,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	76.35M	136.95M	147.90M	145.87M	160.69M	[{"date":"2020-12-31","value":47.52,"profit":true},{"date":"2021-12-31","value":85.23,"profit":true},{"date":"2022-12-31","value":92.04,"profit":true},{"date":"2023-12-31","value":90.78,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	169.00K	172.00K	174.00K	17.00K	18.00K	[{"date":"2020-12-31","value":97.13,"profit":true},{"date":"2021-12-31","value":98.85,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":9.77,"profit":true},{"date":"2024-12-31","value":10.34,"profit":true}]
Retained Earnings	(1.31B)	(1.32B)	(1.38B)	(1.41B)	(1.39B)	[{"date":"2020-12-31","value":-130597200000,"profit":false},{"date":"2021-12-31","value":-132388600000,"profit":false},{"date":"2022-12-31","value":-138245900000,"profit":false},{"date":"2023-12-31","value":-140755000000,"profit":false},{"date":"2024-12-31","value":-139006500000,"profit":false}]
Other Stockholders' Equity	1.34B	1.35B	1.37B	1.38B	1.39B	[{"date":"2020-12-31","value":96.16,"profit":true},{"date":"2021-12-31","value":97.19,"profit":true},{"date":"2022-12-31","value":98.24,"profit":true},{"date":"2023-12-31","value":98.96,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	34.03M	30.37M	(13.62M)	(28.64M)	3.29M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":89.27,"profit":true},{"date":"2022-12-31","value":-40.02,"profit":false},{"date":"2023-12-31","value":-84.18,"profit":false},{"date":"2024-12-31","value":9.66,"profit":true}]

Total Liabilities & Shareholders Equity	110.38M	167.33M	134.28M	117.22M	163.98M	[{"date":"2020-12-31","value":65.97,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":80.25,"profit":true},{"date":"2023-12-31","value":70.06,"profit":true},{"date":"2024-12-31","value":98,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	-	73.59%	(24.97%)	(14.35%)	36.10%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-33.92,"profit":false},{"date":"2023-12-31","value":-19.51,"profit":false},{"date":"2024-12-31","value":49.06,"profit":true}]
Non-current Assets	-	(39.89%)	42.88%	(2.27%)	60.77%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-65.64,"profit":false},{"date":"2022-12-31","value":70.56,"profit":true},{"date":"2023-12-31","value":-3.73,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	-	51.60%	(19.75%)	(12.70%)	39.88%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-38.28,"profit":false},{"date":"2023-12-31","value":-24.62,"profit":false},{"date":"2024-12-31","value":77.3,"profit":true}]

Total Liabilities
Current Liabilities	-	55.61%	2.61%	(18.32%)	18.83%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":4.69,"profit":true},{"date":"2023-12-31","value":-32.93,"profit":false},{"date":"2024-12-31","value":33.87,"profit":true}]
Non-current Liabilities	-	106.70%	12.65%	12.00%	5.17%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":11.85,"profit":true},{"date":"2023-12-31","value":11.24,"profit":true},{"date":"2024-12-31","value":4.84,"profit":true}]
Total Liabilities	-	79.37%	7.99%	(1.37%)	10.16%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":10.07,"profit":true},{"date":"2023-12-31","value":-1.73,"profit":false},{"date":"2024-12-31","value":12.8,"profit":true}]

Total Shareholders' equity
Common Stock	-	1.78%	1.16%	(90.23%)	5.88%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":30.18,"profit":true},{"date":"2022-12-31","value":19.77,"profit":true},{"date":"2023-12-31","value":-1533.91,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	-	1.37%	4.42%	1.81%	(1.24%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":31,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":41.02,"profit":true},{"date":"2024-12-31","value":-28.08,"profit":false}]
Other Stockholders' Equity	-	1.07%	1.08%	0.73%	1.05%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":99.17,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":68.01,"profit":true},{"date":"2024-12-31","value":96.95,"profit":true}]
Total Shareholders' equity	-	(10.73%)	(144.83%)	110.37%	(111.48%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-9.72,"profit":false},{"date":"2022-12-31","value":-131.22,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-101,"profit":false}]

Total Liabilities & Shareholders Equity	-	51.60%	(19.75%)	(12.70%)	39.88%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-38.28,"profit":false},{"date":"2023-12-31","value":-24.62,"profit":false},{"date":"2024-12-31","value":77.3,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	106.47M	135.10M	146.56M	175.39M	214.93M	[{"date":"2024-09-30","value":49.54,"profit":true},{"date":"2024-12-31","value":62.86,"profit":true},{"date":"2025-03-31","value":68.19,"profit":true},{"date":"2025-06-30","value":81.61,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Assets	32.95M	28.87M	29.41M	31.34M	27.61M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":87.62,"profit":true},{"date":"2025-03-31","value":89.25,"profit":true},{"date":"2025-06-30","value":95.12,"profit":true},{"date":"2025-09-30","value":83.78,"profit":true}]
Total Assets	139.42M	163.98M	175.97M	206.74M	242.53M	[{"date":"2024-09-30","value":57.48,"profit":true},{"date":"2024-12-31","value":67.61,"profit":true},{"date":"2025-03-31","value":72.56,"profit":true},{"date":"2025-06-30","value":85.24,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	54.31M	63.30M	66.63M	86.64M	94.40M	[{"date":"2024-09-30","value":57.53,"profit":true},{"date":"2024-12-31","value":67.05,"profit":true},{"date":"2025-03-31","value":70.58,"profit":true},{"date":"2025-06-30","value":91.78,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	99.74M	97.39M	90.78M	38.17M	30.52M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":97.64,"profit":true},{"date":"2025-03-31","value":91.01,"profit":true},{"date":"2025-06-30","value":38.26,"profit":true},{"date":"2025-09-30","value":30.6,"profit":true}]
Total Liabilities	154.06M	160.69M	157.41M	124.80M	124.92M	[{"date":"2024-09-30","value":95.87,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":97.96,"profit":true},{"date":"2025-06-30","value":77.67,"profit":true},{"date":"2025-09-30","value":77.74,"profit":true}]

Total Shareholders' equity
Common Stock	17.00K	18.00K	18.00K	18.00K	18.00K	[{"date":"2024-09-30","value":94.44,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(1.40B)	(1.39B)	(1.38B)	(1.32B)	(1.29B)	[{"date":"2024-09-30","value":-140440600000,"profit":false},{"date":"2024-12-31","value":-139006500000,"profit":false},{"date":"2025-03-31","value":-137861900000,"profit":false},{"date":"2025-06-30","value":-131900600000,"profit":false},{"date":"2025-09-30","value":-129110600000,"profit":false}]
Other Stockholders' Equity	1.39B	1.39B	1.40B	1.40B	1.41B	[{"date":"2024-09-30","value":98.66,"profit":true},{"date":"2024-12-31","value":98.92,"profit":true},{"date":"2025-03-31","value":99.19,"profit":true},{"date":"2025-06-30","value":99.45,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	(14.64M)	3.29M	18.57M	81.93M	117.61M	[{"date":"2024-09-30","value":-12.44,"profit":false},{"date":"2024-12-31","value":2.8,"profit":true},{"date":"2025-03-31","value":15.79,"profit":true},{"date":"2025-06-30","value":69.67,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	139.42M	163.98M	175.97M	206.74M	242.53M	[{"date":"2024-09-30","value":57.48,"profit":true},{"date":"2024-12-31","value":67.61,"profit":true},{"date":"2025-03-31","value":72.56,"profit":true},{"date":"2025-06-30","value":85.24,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	26.90%	8.48%	19.67%	22.54%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":31.54,"profit":true},{"date":"2025-06-30","value":73.13,"profit":true},{"date":"2025-09-30","value":83.8,"profit":true}]
Non-current Assets	-	(12.38%)	1.86%	6.58%	(11.92%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-188.23,"profit":false},{"date":"2025-03-31","value":28.23,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-181.26,"profit":false}]
Total Assets	-	17.61%	7.32%	17.48%	17.32%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":41.53,"profit":true},{"date":"2025-06-30","value":99.25,"profit":true},{"date":"2025-09-30","value":98.31,"profit":true}]

Total Liabilities
Current Liabilities	-	16.55%	5.26%	30.03%	8.96%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":55.11,"profit":true},{"date":"2025-03-31","value":17.52,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":29.84,"profit":true}]
Non-current Liabilities	-	(2.36%)	(6.79%)	(57.96%)	(20.02%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Total Liabilities	-	4.31%	(2.04%)	(20.71%)	0.10%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-47.45,"profit":false},{"date":"2025-06-30","value":-481.07,"profit":false},{"date":"2025-09-30","value":2.29,"profit":true}]

Total Shareholders' equity
Common Stock	-	5.88%	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Retained Earnings	-	(1.02%)	(0.82%)	(4.32%)	(2.12%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Other Stockholders' Equity	-	0.26%	0.28%	0.27%	0.55%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":47,"profit":true},{"date":"2025-03-31","value":50.31,"profit":true},{"date":"2025-06-30","value":48.87,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	-	(122.47%)	464.69%	341.29%	43.54%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-26.35,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":73.44,"profit":true},{"date":"2025-09-30","value":9.37,"profit":true}]

Total Liabilities & Shareholders Equity	-	17.61%	7.32%	17.48%	17.32%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":41.53,"profit":true},{"date":"2025-06-30","value":99.25,"profit":true},{"date":"2025-09-30","value":98.31,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	(52.19M)	5.88M	(73.76M)	(5.74M)	31.47M	[{"date":"2020-12-31","value":-165.82,"profit":false},{"date":"2021-12-31","value":18.68,"profit":true},{"date":"2022-12-31","value":-234.37,"profit":false},{"date":"2023-12-31","value":-18.25,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	47.47M	(80.04M)	72.78M	(4.30M)	4.13M	[{"date":"2020-12-31","value":65.22,"profit":true},{"date":"2021-12-31","value":-109.97,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-5.9,"profit":false},{"date":"2024-12-31","value":5.67,"profit":true}]

Financing Activities
Net Financing Cash Flow	12.57M	62.67M	6.55M	18.37M	(11.64M)	[{"date":"2020-12-31","value":20.06,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":10.45,"profit":true},{"date":"2023-12-31","value":29.31,"profit":true},{"date":"2024-12-31","value":-18.57,"profit":false}]

Net Change in Cash	7.85M	(11.48M)	5.57M	8.33M	23.96M	[{"date":"2020-12-31","value":32.77,"profit":true},{"date":"2021-12-31","value":-47.93,"profit":false},{"date":"2022-12-31","value":23.24,"profit":true},{"date":"2023-12-31","value":34.75,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(53.45M)	5.25M	(74.21M)	(20.74M)	31.07M	[{"date":"2020-12-31","value":-171.99,"profit":false},{"date":"2021-12-31","value":16.9,"profit":true},{"date":"2022-12-31","value":-238.8,"profit":false},{"date":"2023-12-31","value":-66.75,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	(111.26%)	(1354.81%)	(92.21%)	(647.99%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(268.62%)	(190.93%)	(105.90%)	(196.11%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	398.57%	(89.55%)	180.41%	(163.38%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-22.47,"profit":false},{"date":"2023-12-31","value":45.27,"profit":true},{"date":"2024-12-31","value":-40.99,"profit":false}]

Net Change in Cash	-	(246.24%)	(148.50%)	49.52%	187.74%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-131.16,"profit":false},{"date":"2022-12-31","value":-79.1,"profit":false},{"date":"2023-12-31","value":26.38,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	(109.82%)	(1513.22%)	(72.05%)	(249.81%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	21.68M	14.50M	(893.00K)	30.54M	24.03M	[{"date":"2024-09-30","value":70.99,"profit":true},{"date":"2024-12-31","value":47.49,"profit":true},{"date":"2025-03-31","value":-2.92,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":78.69,"profit":true}]

Investing Activities
Net Investing Cash Flow	3.80M	(10.91M)	(10.55M)	(23.28M)	(33.17M)	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":-287.06,"profit":false},{"date":"2025-03-31","value":-277.54,"profit":false},{"date":"2025-06-30","value":-612.2,"profit":false},{"date":"2025-09-30","value":-872.57,"profit":false}]

Financing Activities
Net Financing Cash Flow	(9.84M)	1.47M	484.00K	418.00K	4.27M	[{"date":"2024-09-30","value":-230.44,"profit":false},{"date":"2024-12-31","value":34.3,"profit":true},{"date":"2025-03-31","value":11.33,"profit":true},{"date":"2025-06-30","value":9.79,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Net Change in Cash	15.64M	5.05M	(10.96M)	7.68M	(4.87M)	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":32.32,"profit":true},{"date":"2025-03-31","value":-70.09,"profit":false},{"date":"2025-06-30","value":49.1,"profit":true},{"date":"2025-09-30","value":-31.16,"profit":false}]

Free Cash Flow
Free Cash Flow	21.67M	14.48M	(893.00K)	30.54M	24.02M	[{"date":"2024-09-30","value":70.96,"profit":true},{"date":"2024-12-31","value":47.41,"profit":true},{"date":"2025-03-31","value":-2.92,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":78.66,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	(33.10%)	(106.16%)	(3519.60%)	(21.31%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(387.06%)	(3.32%)	120.58%	42.53%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-320.99,"profit":false},{"date":"2025-03-31","value":-2.75,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":35.27,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	(114.89%)	(66.96%)	(13.64%)	921.77%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-12.46,"profit":false},{"date":"2025-03-31","value":-7.26,"profit":false},{"date":"2025-06-30","value":-1.48,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Net Change in Cash	-	(67.68%)	(316.88%)	(170.06%)	(163.46%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(33.19%)	(106.17%)	(3519.60%)	(21.34%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Rigel Pharmaceuticals Inc Ratios

Rigel Pharmaceuticals Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	RIGL
Cash Ratio	1.45
Current Ratio	2.28
Quick Ratio	2.06

Rigel Pharmaceuticals Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	RIGL
ROA (LTM)	38.93%
ROE (LTM)	220.06%

Rigel Pharmaceuticals Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	RIGL
Debt Ratio Lower is generally better. Negative is bad.	0.52
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.48

Rigel Pharmaceuticals Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	RIGL
Trailing PE	5.54
Forward PE	10.93
P/S (TTM)	2.21
P/B	5.30
Price/FCF	26
EV/R	1.94
EV/Ebitda	4.40
PEG	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Rigel Pharmaceuticals Inc share price today?

Rigel Pharmaceuticals Inc (RIGL) share price today is $35.72

Can Indians buy Rigel Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Rigel Pharmaceuticals Inc (RIGL) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RIGL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Rigel Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Rigel Pharmaceuticals Inc (RIGL) via the Vested app. You can start investing in Rigel Pharmaceuticals Inc (RIGL) with a minimum investment of $1.

How to invest in Rigel Pharmaceuticals Inc shares from India?

You can invest in shares of Rigel Pharmaceuticals Inc (RIGL) via Vested in three simple steps:

Click on Sign Up or Invest in RIGL stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Rigel Pharmaceuticals Inc shares

What is Rigel Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Rigel Pharmaceuticals Inc (RIGL) is $52.24. The 52-week low price of Rigel Pharmaceuticals Inc (RIGL) is $15.5.

What is Rigel Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Rigel Pharmaceuticals Inc (RIGL) is 5.5444

What is Rigel Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Rigel Pharmaceuticals Inc (RIGL) is 5.30

What is Rigel Pharmaceuticals Inc dividend yield?

The dividend yield of Rigel Pharmaceuticals Inc (RIGL) is 0.00%

What is the Market Cap of Rigel Pharmaceuticals Inc?

The market capitalization of Rigel Pharmaceuticals Inc (RIGL) is $645.28M

What is Rigel Pharmaceuticals Inc's stock symbol?

The stock symbol (or ticker) of Rigel Pharmaceuticals Inc is RIGL

How Can Investors Use Rigel Pharmaceuticals Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Rigel Pharmaceuticals Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Rigel Pharmaceuticals Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Rigel Pharmaceuticals Inc shares for Indian investors?

When investing in Rigel Pharmaceuticals Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Rigel Pharmaceuticals Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Rigel Pharmaceuticals Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Rigel Pharmaceuticals Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Rigel Pharmaceuticals Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Rigel Pharmaceuticals Inc Share Price

Rigel Pharmaceuticals Inc Analyst Forecast

Rigel Pharmaceuticals Inc Share Price Chart

Rigel Pharmaceuticals Inc Key Stock Metrics

About Rigel Pharmaceuticals Inc, Common Stock

Rigel Pharmaceuticals Inc Stock Returns

Rigel Pharmaceuticals Inc Financials

Rigel Pharmaceuticals Inc Ratios

Rigel Pharmaceuticals Inc Liquidity Ratios

Rigel Pharmaceuticals Inc Asset Efficiency Ratios

Rigel Pharmaceuticals Inc Liability Ratios

Rigel Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Rigel Pharmaceuticals Inc Share Price

Rigel Pharmaceuticals Inc Analyst Forecast

Rigel Pharmaceuticals Inc Share Price Chart

Rigel Pharmaceuticals Inc Key Stock Metrics

About Rigel Pharmaceuticals Inc, Common Stock

Rigel Pharmaceuticals Inc Stock Returns

Rigel Pharmaceuticals Inc Financials

Rigel Pharmaceuticals Inc Ratios

Rigel Pharmaceuticals Inc Liquidity Ratios

Rigel Pharmaceuticals Inc Asset Efficiency Ratios

Rigel Pharmaceuticals Inc Liability Ratios

Rigel Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²